title: Synergism between cAMP and PPARγ Signalling in the Initiation of UCP1 Gene Expression in HIB1B Brown Adipocytes.
abstract: Expression of the brown adipocyte-specific gene, uncoupling protein 1 (UCP1), is increased by both PPARγ stimulation and cAMP activation through their ability to stimulate the expression of the PPAR coactivator PGC1α. In HIB1B brown preadipocytes, combination of the PPARγ agonist, rosiglitazone, and the cAMP stimulator forskolin synergistically increased UCP1 mRNA expression, but PGC1α expression was only increased additively by the two drugs. The PPARγ antagonist, GW9662, and the PKA inhibitor, H89, both inhibited UCP1 expression stimulated by rosiglitazone and forskolin but PGC1α expression was not altered to the same extent. Reporter studies demonstrated that combined rosiglitazone and forskolin synergistically activated transcription from a full length 3.1 kbp UCP1 luciferase promoter construct, but the response was only additive and much reduced when a minimal 260 bp proximal UCP1 promoter was examined. Rosiglitazone and forskolin in combination were able to synergistically stimulate promoters comprising of tandem repeats of either PPREs or CREs. We conclude that rosiglitazone and forskolin act together to synergistically activate the UCP1 promoter directly rather than by increasing PGC1α expression and by a mechanism involving cross-talk between the signalling systems regulating the CRE and PPRE on the promoters.
authors.affiliation: School of Biosciences, Division of Nutritional Sciences, University of Nottingham, Sutton Bonington Campus, Loughborough, Leicestershire LE125RD, UK.
authors.forename: H Y
authors.initials: HY
authors.lastname: Chen
authors.forename: Q
authors.initials: Q
authors.lastname: Liu
authors.forename: A M
authors.initials: AM
authors.lastname: Salter
authors.forename: M A
authors.initials: MA
authors.lastname: Lomax
references.citation: Biochem Pharmacol. 2006 Jun 28;72(1):42-52
references.pmid: 16696951
references.citation: J Biol Chem. 1996 Nov 22;271(47):29909-14
references.pmid: 8939934
references.citation: Endocrinology. 2006 Jun;147(6):2829-38
references.pmid: 16513826
references.citation: J Biol Chem. 2003 Aug 29;278(35):33370-6
references.pmid: 12807871
references.citation: Mol Cell Biol. 2004 Apr;24(7):3057-67
references.pmid: 15024092
references.citation: Diabetologia. 2010 Jun;53(6):1164-73
references.pmid: 20238096
references.citation: Nature. 2009 Apr 9;458(7239):757-61
references.pmid: 19194461
references.citation: Physiol Rev. 2004 Jan;84(1):277-359
references.pmid: 14715917
references.citation: Nature. 2009 Aug 27;460(7259):1154-8
references.pmid: 19641492
references.citation: Cell Metab. 2009 Jan 7;9(1):99-109
references.pmid: 19117550
references.citation: Am J Physiol Regul Integr Comp Physiol. 2010 Jul;299(1):R159-67
references.pmid: 20393157
references.citation: J Biol Chem. 2007 Aug 24;282(34):24660-9
references.pmid: 17584738
references.citation: Mol Cell Biol. 2009 Sep;29(17):4714-28
references.pmid: 19564408
references.citation: FEBS Lett. 2006 Aug 21;580(19):4661-6
references.pmid: 16876797
references.citation: Nature. 2008 Aug 21;454(7207):961-7
references.pmid: 18719582
references.citation: J Biol Chem. 2009 Jul 31;284(31):20738-52
references.pmid: 19491401
references.citation: J Biol Chem. 2003 Jan 3;278(1):263-9
references.pmid: 12414803
references.citation: J Biol Chem. 2010 Mar 5;285(10):7153-64
references.pmid: 20028987
references.citation: Am J Physiol Endocrinol Metab. 2008 Aug;295(2):E287-96
references.pmid: 18492776
references.citation: Front Endocrinol (Lausanne). 2012 Feb 06;3:14
references.pmid: 22654854
references.citation: Cell Metab. 2010 Apr 7;11(4):257-62
references.pmid: 20374957
references.citation: J Biol Chem. 2002 Sep 13;277(37):34589-600
references.pmid: 12084707